Provided by Tiger Fintech (Singapore) Pte. Ltd.

Moderna, Inc.

27.16
-0.9800-3.48%
Post-market: 27.170.0100+0.04%19:59 EDT
Volume:15.70M
Turnover:428.25M
Market Cap:10.61B
PE:-3.61
High:27.87
Open:27.83
Low:26.87
Close:28.14
52wk High:56.70
52wk Low:23.15
Shares:390.58M
Float Shares:363.29M
Volume Ratio:0.99
T/O Rate:4.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.5273
EPS(LYR):-9.2734
ROE:-27.50%
ROA:-14.78%
PB:1.13
PE(LYR):-2.93

Loading ...

Health Rounds: mRNA COVID vaccines appear to make immunotherapy cancer drugs work better

Reuters
·
Oct 22

Moderna (MRNA) Gets a Hold from Bernstein

TIPRANKS
·
Oct 21

Moderna Publishes Study on mRNA-1345 RSV Vaccine in Solid Organ Transplant Recipients

Reuters
·
Oct 21

Moderna Inc. Stock Rises 4.7%, Outperforms Peers

Dow Jones
·
Oct 21

Small Caps Rally As Credit Fears Ease, Gold Rebounds To $4,350: What's Moving Markets Monday?

Benzinga_recent_news
·
Oct 21

Super Micro Is 1 of the S&P 500's Top Gainers. The Stock Could Break Out. -- Barrons.com

Dow Jones
·
Oct 21

BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT

Reuters
·
Oct 21

US Stocks Update | Moderna (MRNA.US) Rises Over 7% on Positive Data for Two New mRNA Vaccines

Stock News
·
Oct 20

Moderately bullish activity in Moderna with shares up 7.5%

TIPRANKS
·
Oct 20

Moderna Reports Positive Results for mRNA Flu Vaccines in Clinical Trials

Reuters
·
Oct 20

Stock Track | Moderna Soars 5% as Government Renews COVID-19 Immunization Strategy

Stock Track
·
Oct 20

Oppenheimer Reaffirms Their Hold Rating on Moderna (MRNA)

TIPRANKS
·
Oct 20

Hold Rating on Moderna’s mRNA-4359: Promising Early Data but Awaiting Further Validation

TIPRANKS
·
Oct 20

Stock Market Today: S&P 500, Nasdaq, Dow Jones Futures Rise— Micron, Bitmine, Coinbase In Focus

Benzinga
·
Oct 20

Moderna announces data on flu, pandemic flu candidates at IDWeek 2025

TIPRANKS
·
Oct 19

How Moderna's (MRNA) mRNA-4359 Cancer Vaccine Data Is Shaping Its Pipeline Diversification Narrative

Simply Wall St.
·
Oct 19

Moderna Inc. Stock Slides 4.2%, Underperforms Peers

Dow Jones
·
Oct 18

Moderna Shares Fall After Early Trial Update on mRNA-4359 Cancer Vaccine Combination

MT Newswires Live
·
Oct 18

Stock Track | Moderna Plummets 5% as Oncology Drug Update Disappoints Investors

Stock Track
·
Oct 18

Stock Track | Moderna Plummets 5% Following Oncology Update on mRNA-4359 Study

Stock Track
·
Oct 18